European urology oncology : Impact Factor & More
eISSN: 2588-9311pISSN: 2588-9311
Share this on:
Aims and Scope of European urology oncology
European Urology Oncology is the new sister journal to European Urology and European Urology Focus, and the first official publication of the EAU fully devoted to the study of genitourinary malignancies. Less
Key Metrics
CiteScore 
9.4
Eigenfactor
0.001 - 0.005
Impact Factor
5 - 10
SJR
Q2Surgery
SNIP
2.02
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on European urology oncology
European urology oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | ELSEVIER |
| Language | English |
| Frequency | Bi-monthly |
| General Details | |
| Language | English |
| Frequency | Bi-monthly |
| Publication Start Year | 2018 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in European urology oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in European urology oncology
Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
- 31 Jan 2027
- European urology oncology
Overall Survival Benefit from Metformin in High-volume Metastatic Hormone-sensitive Prostate Cancer in STAMPEDE Signals an Opportunity for Metabolically-targeted Therapies in Prostate Cancer.
- 30 Jun 2026
- European urology oncology
PROTEUS: A Practice-changing Trial, but Are We Ready to Embrace Perioperative Apalutamide for All High-risk Patients?
- 30 Jun 2026
- European urology oncology
Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin±Pembrolizumab.
- 30 Jun 2026
- European urology oncology
Dynamic Changes in Tumor Burden in Patients Undergoing PSMA RLT.
- 30 Jun 2026
- European urology oncology
Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Real-world Data from a National Early Access Program Registry.
- 29 Jun 2026
- European urology oncology
Prostate Cancer Care for Men with an Intellectual Disability: A Population-based Cohort Study of Symptoms, Diagnosis, Treatment, and Survival.
- 31 Jan 2027
- European urology oncology
Overall Survival Benefit from Metformin in High-volume Metastatic Hormone-sensitive Prostate Cancer in STAMPEDE Signals an Opportunity for Metabolically-targeted Therapies in Prostate Cancer.
- 30 Jun 2026
- European urology oncology
PROTEUS: A Practice-changing Trial, but Are We Ready to Embrace Perioperative Apalutamide for All High-risk Patients?
- 30 Jun 2026
- European urology oncology
Prognostic Implications of Personalized Circulating Tumor DNA Testing in Patients with Advanced Urothelial Carcinoma Treated with Enfortumab Vedotin±Pembrolizumab.
- 30 Jun 2026
- European urology oncology
Dynamic Changes in Tumor Burden in Patients Undergoing PSMA RLT.
- 30 Jun 2026
- European urology oncology
Pembrolizumab After Nephrectomy for High-risk Renal Cell Carcinoma: Real-world Data from a National Early Access Program Registry.
- 29 Jun 2026
- European urology oncology
FAQs on European urology oncology
How long has European urology oncology been actively publishing? 
What is the publishing frequency of European urology oncology?
How many articles did European urology oncology publish last year?
What is the eISSN & pISSN for European urology oncology?
What is Citescore for European urology oncology?
What is SNIP score for European urology oncology?
What is the SJR for European urology oncology?
Who is the publisher of European urology oncology?
